· 个股论点

分析NBIS受ATM及空头压制,但基本面强劲且机构增持,高波动需耐心持有。

涉及标的:

中文翻译

就我个人对 $NBIS 的观察来看,其表现主要受定向增发(ATM)抛压、板块拖累、短期空头以及19日到期的巨额未平仓合约影响。例如,$CRWV 昨日上涨5.13%,而 $NBIS 同日下跌3.91%,我认为这归因于空头或ATM操作。有些令人遗憾,尽管 $NBIS 是降息的最大受益者(新云(neocloud)板块),但今天下跌2%,而其他散户宠儿如 $RKLB 却上涨8%+。价格走势有时会让你自我怀疑,但即使有10%的稀释,也改变不了你提到的事实:Nebius 2026年底年化经常性收入(ARR)中值为80亿美元,与Avride推出了Robotaxis,与 $META 达成30亿美元交易,Clickhouse增长极快,另外两家子公司同比增长100%,其中Toloka受益于 $META 的Scale收购。机构持股比例目前可能接近52%(上月彭博终端显示50%多,MSCI调整前),较上季度的30%多高,机构确实在从投降的散户手中收购股份。此时持有很痛苦,但请记住作为市场上最高贝塔(beta)股票之一,它在一周内可能波动35%。(在2-3周内从100美元到140美元到95美元再到130美元)。

英文原文

So from what I've seen personally with $NBIS, it's largely ATM overhang + sector drag + short term shorts, and large amounts of open interest expiring on the 19th. For example, $CRWV was up 5.13% yesterday, while $NBIS was down 3.91% same day, and I'd attribute that to either shorts/ATMs. It's a little unfortunate, even as the largest beneficiary of rate cuts (neocloud sector), $NBIS is down 2% today while other retail favorites like $RKLB are up 8%+. Price action makes you doubt yourself sometimes, but even with 10% dilution, it doesn't really change the fact as you mentioned Nebius has $8B midpoint ARR EOY 2026, they launched Robotaxis with Avride, $META $3B deal, Clickhouse is growing incredibly fast, and their other two subsidaries are growing 100% Y/Y with Toloka benefiting from $META Scale acquisition. Institutional ownership is now probably closer to 52%(bloomberg terminal 50's last month pre msci) from high 30's last quarter and institutions are definitely acquiring shares from retail capitulating. Painful hold at this point, but keep in mind it can move 35% on a random week as one of the highest beta stocks in the market. (went from $100 to $140 to $95 to $130 in the span of 2-3 weeks).

在 X 上查看原推 ↗